Literature DB >> 10686593

Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain.

C S Armstrong1, L Wuarin, D N Ishii.   

Abstract

Brain injury has been prevented recently by systemic administration of human insulin-like growth factor-I (hIGF-I). It is widely believed that protein neurotrophic factors do not enter the brain from blood, and the mechanism by which circulating hIGF-I may be neuroprotective is uncertain. This investigation tested the hypothesis that hIGF-I is taken up into cerebrospinal fluid (CSF) from the circulation. (125)I-hIGF-I was injected subcutaneously into rats. The (125)I-IGF-I recovered from CSF and plasma were indistinguishable in size from authentic (125)I-hIGF-I on SDS-PAGE. An ELISA was used that detected immunoreactive hIGF-I, but not rat IGF-I, rat IGF-II, human IGF-II, or insulin. Osmotic minipumps were implanted for constant subcutaneous infusion of various hIGF-I doses. Uptake into CSF reached a plateau at plasma concentrations above approximately 150 ng/ml hIGF-I; the plateau was consistent with carrier-mediated uptake. The plasma, but not CSF, hIGF-I level was significantly reduced in streptozotocin diabetic vs. nondiabetic rats, and uptake of hIGF-I into CSF was nonlinear with respect to plasma hIGF-I concentrations. Nonlinear uptake excluded leakage or transmembrane diffusion of IGF-I from blood into CSF as a dominant route for entry, but the site and mechanism of uptake remain to be established. The IGF-II mRNA content per milligram brain (P < 0.02) as well as per poly(A)(+) RNA (P < 0.05) was significantly increased towards normal in diabetic rats treated by subcutaneous administration of hIGF-I vs. vehicle. This effect of circulating hIGF-I may have been due to regulation of IGF-II gene expression in the choroid plexus and leptomeninges, structures at least in part outside of the blood-central nervous system barrier. These data support the hypothesis that circulating IGF-I supports the brain indirectly through regulation of IGF-II gene expression as well as by uptake into the CSF. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686593     DOI: 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR8>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

1.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

2.  Cochlear hearing loss in patients with Laron syndrome.

Authors:  Joseph Attias; Omer Zarchi; Ben I Nageris; Zvi Laron
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-08       Impact factor: 2.503

3.  Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.

Authors:  Marta Bolós; Silvia Fernandez; Ignacio Torres-Aleman
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

Review 4.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

Review 5.  Serum growth factors and neuroprotective surveillance: focus on IGF-1.

Authors:  I Torres-Aleman
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

6.  Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner.

Authors:  D Chrysis; A S Calikoglu; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Insulin and Insulin-like Growth Factor 1 (IGF-1) Modulate Cytoplasmic Glucose and Glycogen Levels but Not Glucose Transport across the Membrane in Astrocytes.

Authors:  Marko Muhič; Nina Vardjan; Helena H Chowdhury; Robert Zorec; Marko Kreft
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

8.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

9.  Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats.

Authors:  Rina Eshet; Irit Gil-Ad; Olga Apelboym; Yael Segev; Moshe Phillip; Haim Werner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum.

Authors:  Kun Hua; M Elizabeth Forbes; Robin J Lichtenwalner; William E Sonntag; David R Riddle
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.